Text Version     PDF Version     To Publications Page     To Home Page

To Home Page.

 

National Drug Intelligence Center.

UNCLASSIFIED

Title:

Washington/Baltimore High Intensity Drug Trafficking Area Drug Market Analysis

Publication Date: June 2007

Document ID: 2007-R0813-004

This assessment is an outgrowth of a partnership between the NDIC and HIDTA Program for preparation of annual assessments depicting drug trafficking trends and developments in HIDTA Program areas. The report has been vetted with the HIDTA, is limited in scope to HIDTA jurisdictional boundaries, and draws upon a wide variety of sources within those boundaries.

Your questions, comments, and suggestions for future subjects are welcome at any time. Addresses are provided at the end of the page.

To Home Page.

Washington/Baltimore HIDTA seal.


Contents

Preface

Strategic Drug Threat Developments

HIDTA Overview

Drug Threat Overview

 

Drug Trafficking Organizations

Production

Transportation

Distribution

Abuse

 

Drug-Related Crime

Illicit Finance

Outlook

Sources


List of Figures

Figure 1. Washington/Baltimore High Intensity Drug Trafficking Area.
Figure 2. Washington/Baltimore HIDTA transportation infrastructure.


Preface

Figure 1. Washington/Baltimore High Intensity Drug Trafficking Area.

Map showing the Washington/Baltimore High Intensity Drug Trafficking Area.
d-link

This assessment provides a strategic overview of the illicit drug situation in the Washington/Baltimore (W/B) High Intensity Drug Trafficking Area (HIDTA), highlighting significant trends and law enforcement concerns relating to the trafficking and abuse of illicit drugs. The report was prepared through detailed analysis of recent law enforcement reporting, information obtained through interviews with law enforcement and public health officials, and available statistical data. The report is designed to provide policymakers, resource planners, and law enforcement officials with a focused discussion of key drug issues and developments facing the W/B HIDTA.

To Top     To Contents


Addresses

National Drug Intelligence Center
319 Washington Street, 5th Floor
Johnstown, PA 15901-1622

Tel. (814) 532-4601
FAX (814) 532-4690
E-mail NDIC.Contacts@usdoj.gov

National Drug Intelligence Center
United States Department of Justice
Robert F. Kennedy Building (Room 1335)
950 Pennsylvania Avenue NW
Washington, DC 20530

Tel. (202) 432-4040
FAX (202) 514-4252

 

Web Addresses

ADNET:  http://ndicosa
DOJ:  http://www.usdoj.gov/ndic/
LEO:  https://cgate.leo.gov/http/leowcs.leopriv.gov/lesig/ndic/index.htm
RISS:  ndic.riss.net


To Top     To Contents     To Next Page

To Publications Page     To Home Page

UNCLASSIFIED


End of page.